What is Syndax Pharmaceuticals's PP&E (net)?

Syndax Pharmaceuticals (SNDX) reported PP&E (net) of $177K in Q1 2026.

What is the long-term trend for Syndax Pharmaceuticals's PP&E (net)?

Over 5 years (2020 to 2025), Syndax Pharmaceuticals's PP&E (net) has grown at a -1.2% compound annual growth rate (CAGR), from $192K to $181K.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Syndax Pharmaceuticals SNDX PP&E (Net)

PP&E (Net) at other companies

BiogenBIIB

$3.02B-3.7%

IncyteINCY

$720.17M-5.9%

AbbVieABBV

$5.69B+8.6%

Viridian Therapeutics, Inc.VRDN

$1.13M-2.8%

Nuvation BioNUVB

$535K-4.8%

ImmunomeIMNM

$17.08M+55.9%

Other financials

Income statement

See full

Revenue$64.9M+224%

Operating income-$34.2M+59.2%

Net income-$42.7M+49.7%

EPS (diluted)-$0.48+51.0%

Balance sheet

See full

Cash & equivalents$130.9M-15.0%

Total debt$350.5M+4.2%

Total equity$41.6M-80.6%

Total assets$472.7M-26.2%

Cash flow

See full

Operating cash flow-$50.3M+47.1%

CapEx$46.8K—

Free cash flow-$80.8M-17.6%

Valuation

See full

Market cap$1.74B+95.0%

Enterprise value$1.96B+84.0%

P/S8×-12.4×

Profitability

See full

Operating margin-102.8%-47.8pp

Net margin-111.9%-51.5pp

FCF margin-187.2%-85.4pp

Returns & leverage

See full

Return on equity-189.5%-8,509pp

Debt / equity8.4×+6.9×

Current ratio5.5×-0.3×

Where this comes from

Reported directly by Syndax Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Syndax Pharmaceuticals's PP&E (net)?: Syndax Pharmaceuticals (SNDX) reported PP&E (net) of $177K in Q1 2026.
What is the long-term trend for Syndax Pharmaceuticals's PP&E (net)?: Over 5 years (2020 to 2025), Syndax Pharmaceuticals's PP&E (net) has grown at a -1.2% compound annual growth rate (CAGR), from $192K to $181K.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.